Form 4: Cimpress CEO Robert Keane Sells Shares Worth Approximately $38,600
SEC Form 4 Filing
Cimpress CEO Robert Keane sold 396 ordinary shares at an average price of $97.5536 on September 5, 2024, according to a Form 4 filing with the SEC.
Summary
- On September 5, 2024, Robert S. Keane, CEO and Chairman of Cimpress plc, sold 396 ordinary shares of the company.
- The sale was executed at a price of $97.5536 per share.
- Following the transaction, Keane directly owns 23,451 ordinary shares.
- Keane also indirectly owns a significant number of shares through various entities, including Third Delaware 2011, LLC (986,785 shares), Keane Family Foundation (220,503 shares), RHS Delaware Holdings LLC (28,375 shares), Eastern Irrevocable, LLC (43,128 shares), Western Irrevocable, LLC (47,088 shares), Delaware 2001, LLC (51,900 shares), and Second Delaware 2003, LLC (780,000 shares).
Sentiment
Score: 5
Explanation: The sentiment is neutral. It's a routine disclosure of a share sale by the CEO. The size of the sale is relatively small compared to his overall holdings, suggesting it's unlikely to be driven by negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's future prospects.
Comparison to Industry Standards
- Comparing Robert Keane's transactions to other CEOs in the printing and marketing services industry is difficult without specific data on their holdings and trading activity.
- However, insider sales are a common occurrence, and the significance of this particular sale would depend on its size relative to Keane's overall holdings and the context of the company's performance.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, but the effect is likely to be minimal given the relatively small size of the transaction.
Key Dates
| Date | Description |
|---|---|
| 09/05/2024 | Date of the share sale transaction. |
| 09/09/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.